Skip to content

A clinical trail to study the effect of electroacupuncture in altering the pain related disability in patients with migraine.

Effect of electroacupuncture to GB44, TE21, ST36 and LR2 on pain and disability in migraineurs: A randomised placebo - controlled trial. - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/02/080150
Enrollment
50
Registered
2025-02-07
Start date
Unknown
Completion date
Unknown
Last updated
2025-03-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: G431- Migraine with aura Health Condition 2: G430- Migraine without aura

Interventions

Intervention1: Electrical stimulation at acupuncture points: Acupuncture needling with electrical stimulus will be given at four points GB44, TE21, ST36 and LR2 with 30 mins retention for 5 days a wee
frequency of 5Hz and the intensity will be adjusted according to patients tolerance.

Sponsors

Government Yoga and Naturopathy Medical College and Hospital
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1) Patients who confirm the diagnostic criteria for migraine stipulated by The International Classification of Headache Disorders, 3rd edition 2) Patients of Migraine with aura (MwA) and Migraine without aura (MwoA) 3) Patients not under drugs for migraine prophylaxis 4) Patients willing to take part in research and give written informed consent

Exclusion criteria

Exclusion criteria: 1) Other primary and secondary types of headaches 2) Cerebral hemorrhage and vascular malformation 3) Stroke 4) Parkinson s and other extrapyramidal diseases 5) History of epilepsy or any mental disorders 6) Intake of anti-psychotic or anti-depressant drugs 7) Neuralgia of face or head 8) Pregnancy, lactation or insufficient contraception 9) Immunodeficiency and bleeding disorders 10) Severe pain syndromes of cervical spine 11) Serious illness such as cancer 12) Patients with metal implants, pacemaker or prosthetics 13) Phobia to needling and electrical stimulation 14) Participation in any other clinical trial

Design outcomes

Primary

MeasureTime frame
Migraine Disability Assessment (MIDAS) QuestionnaireTimepoint: Migraine Disability Assessment (MIDAS) Questionnaire will be measured before and after 2 weeks of intervention

Secondary

MeasureTime frame
Electroencephalogram (EEG)Timepoint: The changes in various frequency bands (alpha, beta, theta and delta) of cortical activity will be measured using EEG before and after 2 weeks of intervention

Countries

India

Contacts

Public ContactDr N Sheeja Begum

Government Yoga and Naturopathy Medical College and Hospital

dr.mooventhan@gmail.com9844457496

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026